Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram

International Journal of Cancer

Volumn 121, Issue 11, 2007, Pages 2556-2561

  Hutterer, Georg C ^a,b   Patard, Jean Jacques ^c   Perrotte, Paul ^d   Ionescu, Constantin ^a   De La Taille, Alexandre ^e   Salomon, Laurent ^e   Verhoest, Gregory ^c   Tostain, Jacques ^f   Cindolo, Luca ^g   Ficarra, Vincenzo ^h   Artibani, Walter ^h   Schips, Luigi ^b   Zigeuner, Richard ^b   Mulders, Peter F ⁱ   Valeri, Antoine ^j   Chautard, Denis ^k   Descotes, Jean Luc ^l   Rambeaud, Jean Jacques ^l   Mejean, Arnaud ^m   Karakiewicz, Pierre I ^a,d  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e HENRI MONDOR HOSPITAL   (France)

^f UNIVERSITÉ JEAN MONNET   (France)

^g G RUMMO HOSPITAL   (Italy)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j BREST UNIVERSITY HOSPITAL   (France)

^k ANGERS UNIVERSITY HOSPITAL   (France)

^l GRENOBLE UNIVERSITY HOSPITAL   (France)

^m Necker Medical School   (France)

more..

Author keywords

Lymph node metastases; Renal cell carcinoma; Stage; Symptom classification

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; HUMAN; KIDNEY CARCINOMA; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NOMOGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOMATOLOGY; TUMOR VOLUME; VALIDATION PROCESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NOMOGRAMS; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS;

EID: 35648980923     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23010     Document Type: Article

References (17)

1. Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 2000;86:20-7.
2. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166:1611-23.
3. Canfield SE, Kamat AM, Sanchez-Ortiz RF, Detry M, Swanson DA, Wood CG. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome. J Urol 2006;175:864-9.
4. Rafla S. Renal cell carcinoma. Natural history and results of treatment. Cancer 1970;25:26-40.
5. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971;28:1165-77.
6. Giuliani L, Giberti C, Martorana G, Rovida S. Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J Urol 1990;143:468-73.
7. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. J Urol 2003;169:2076-83.
8. Johnsen JA, Hellsten S. Lymphatogenous spread of renal cell carcinoma: an autopsy study. J Urol 1997;157:450-3.
9. Karakiewicz PI, Trinh QD, Bhojani N, Bensalah K, Salomon L, de la Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Schips L, Zigeuner R, et al. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol 2007;51:1616-24.
10. Patard JJ, Leray E, Rodriguez A, Rioux-Leclercq N, Guille F, Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol 2003;44:226-32.
11. Karakiewicz P, Perrotte P, Trinh QD, Patard JJ. Rebuttal from Authors Re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1478-80.
12. Briganti A, Chun FK, Salonia A, Zanni G, Scattoni V, Valiquette L, Rigatti P, Montorsi F, Karakiewicz PI. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006;49:1019-27.
13. Karakiewicz PI, Shariat SF, Palapattu GS, Perrotte P, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg M, et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur Urol 2006;50:1254-60.
14. Patard JJ, Rioux-Leclercq N, Fergelot P. Understanding the importance of smart drugs in renal cell carcinoma. Eur Urol 2006;49:633-43.
15. Blom JH, van Poppel H, Marechal JM, Jacqmin D, Sylvester R, Schroder FH, de Prijck L, Members of the EORTC Genitourinary Group. Radical nephrectomy with and without lymph node dissection: preliminary results of the EORTC randomized phase III protocol 30881. Eur Urol 1999;36:570-5.
16. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. J Urol 2002;168:56-60.
17. Dimashkieh HH, Lohse CM, Blute ML, Kwon ED, Leibovich BC, Cheville JC. Extranodal extension in regional lymph nodes is associated with outcome in patients with renal cell carcinoma. J Urol 2006;176:1978-82.